Jane Street Group, LLC Immuno Gen, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$4.26 - $7.48 $23,430 - $41,140	-5,500 Reduced 9.82%	50,500 $240,000
Q4 2021 Feb 15, 2022	BUY	$4.75 - $7.5 $140,600 - $222,000	29,600 Added 112.12%	56,000 $416,000
Q3 2021 Nov 16, 2021	BUY	$5.02 - $6.59 $19,578 - $25,701	3,900 Added 17.33%	26,400 $150,000
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $24,318 - $36,120	-4,200 Reduced 15.73%	22,500 $148,000
Q1 2021 May 18, 2021	BUY	$6.5 - $10.53 $9,750 - $15,794	1,500 Added 5.95%	26,700 $216,000
Q4 2020 Feb 17, 2021	SELL	$3.7 - $7.66 $38,110 - $78,898	-10,300 Reduced 29.01%	25,200 $163,000
Q2 2018 Aug 15, 2018	BUY	$9.52 - $12.15 $242,760 - $309,825	25,500 Added 255.0%	35,500 $345,000
Q4 2017 Feb 15, 2018	BUY	$5.07 - $7.92 $50,700 - $79,200	10,000	10,000 $64,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.